The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

COVID-19 and Cancellation Policy

Source: Rules for tourism businesses and events |

There are currently no corona restrictions in the Netherlands, although basic advice remains in place.

To keep the infection rate within bounds, the basic advice includes:

  • Wash your hands often.
  • Sneeze and cough into your elbow.
  • Do you have symptoms that could be corona? Stay at home and take a self-test. If you test positive, isolate for a minimum of 5 days.
  • Ventilate indoor areas well.
  • Visitors no longer have to show a negative test result. Testing for Access (1G) is not required anymore at any event, large or small.


Registration cancellation policy and substitution policy: 

  1. If the CDDF workshop must be cancelled due to Dutch government restrictions related to COVID-19, you will receive a full (100%) refund of the paid ticket fee.
  2. If you must cancel the registration due to travel restrictions from your home country or country of residence to the Netherlands due to government restrictions, you will receive a full (100%) refund of the paid ticket fee (against proof).
  3. If you must cancel the registration for any other reason, cancellations up until 15 January 2023 will receive a refund of 50% of the ticket fee paid. Cancellations between 16 and 31 January 2023 will receive a refund of 25% of the ticket fee paid.
  4. Cancellations from 1 February 2023 are not eligible for a refund.
  5. If you are unable to attend the CDDF Annual Conference and wish to nominate a substitute, you are welcome to do so. Any change of name must be submitted in writing via email to by 31 January 2023 at the latest.
  6. No refund will be granted for no-shows.

If you are unsure of the rules for entering in the Netherlands from your country of residence, visit this website:

If you have any queries about the cancellation policy, please contact or

Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70